Karen Knudsen, Chief Executive Officer of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“To truly move the dial against cancer, access to potentially life-saving therapeutics is essential. Very much looking forward to working through strategies to increase access to clinical trials at CRAACO 2025.”
More posts featuring Karen Knudsen.